0002055053-25-000001.txt : 20250205 0002055053-25-000001.hdr.sgml : 20250205 20250205170552 ACCESSION NUMBER: 0002055053-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250205 DATE AS OF CHANGE: 20250205 EFFECTIVENESS DATE: 20250205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BTB Therapeutics, Inc. CENTRAL INDEX KEY: 0002055053 ORGANIZATION NAME: IRS NUMBER: 994821536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-537472 FILM NUMBER: 25594256 BUSINESS ADDRESS: STREET 1: 26281 WYNDEMERE COURT CITY: ESCONDIDO STATE: CA ZIP: 92026 BUSINESS PHONE: (858) 945-3733 MAIL ADDRESS: STREET 1: 26281 WYNDEMERE COURT CITY: ESCONDIDO STATE: CA ZIP: 92026 D 1 primary_doc.xml X0708 D LIVE 0002055053 BTB Therapeutics, Inc. 26281 WYNDEMERE COURT ESCONDIDO CA CALIFORNIA 92026 (858) 945-3733 DELAWARE None None Corporation true 2024 Takashi Kiyoizumi 26281 Wyndemere Court Escondido CA CALIFORNIA 92026 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2025-01-30 false true true true 0 3333415 3333333 82 false 10 0 0 0 false BTB Therapeutics, Inc. Takashi Kiyoizumi Takashi Kiyoizumi Chief Executive Officer 2025-01-31